Medical cannabis and cannabinoids

Med Cannabis Cannabinoids · ISSN (e) 2504-3889 · 7 papers in corpus
2025
doi:10.1159/000548890 ·PMID:41384242

BackgroundAt least 60% of individuals with anxiety disorders report sleep disturbances, which might be explained by shared physiological mechanisms, including cortisol dysregulation and executive function skills disruption. The scientific l…

2024
doi:10.1159/000537825 ·PMID:38634042

[This corrects the article DOI: 10.1159/000534044.].

2024
doi:10.1159/000538694 ·PMID:39015606

IntroductionSubjective improvement in gastrointestinal (GI) symptoms was assessed among patients using medical marijuana (MMJ).MethodsParticipants completed surveys at 0 days, 30 days, 6 months, and 12 months with questions about the severi…

2022
doi:10.1159/000521492 ·PMID:35950052

IntroductionMedicinal cannabis is prescribed in Australia for patients with chronic refractory pain conditions. However, measures of safety and effectiveness of different cannabinoids are lacking. We designed an observational study to captu…

2020
2019
2019
doi:10.1159/000499164 ·PMID:34676329

The endocannabinoid system (ECS) is a multifunctional homeostatic system involved in many physiological and pathological conditions. The ligands of the ECS are the endo-cannabinoids, whose actions are mimicked by exogenous cannabinoids, suc…